The New Frontier: How Smartphone Data Can Revolutionize Cancer Care (OurBrainBank in Forbes)
Board member and Harvard Medical School student Jacob Ellen writes about smartphones and brain cancer — not the connection you might think.
Read more
Get Moving in May! For Brain Tumor Awareness Month
Pledge to walk, run, bike, dance, or just fly in your dreams every day in May. Help us raise funds and awareness.
Noted author Julia Hobsbawm is Soul Cycling to benefit OurBrainBank UK
Go Julia! Brilliant thinker and writer Julia Hobsbawm commits to doing 60 Soul Cycle sessions to raise funds for OurBrainBank.
OurBrainBank in Forbes: White House War on GBM and more
Ed Pilkington writes about his experiences and how the White House is working to improve treatment for GBM and all cancers.
OurBrainBank Wins Forbes EQ BrandVoice 2024: First Article Features Jessica Morris’s book
OBB founder Jessica Morris’s book is excerpted by Forbes.
Take our survey about disparities in GBM treatment
Have you or a loved one received a GBM diagnosis? We want to hear about your experience.
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
OurBrainBank UK collaborating with RareCan to improve access to clinical trials
Learn about OurBrainBank UK and RareCan collaboration.
Telluride fundraising event: June 9, 2024
Come raise a glass with us in Telluride to raise funds for OurBrainBank for Glioblastoma.
UK funding initiatives for novel brain tumour research as part of £40m investment
Read the fascinating series on brain tumors, glioblastoma, technological potential, and stories of patient power.
Forbes series on glioblastoma and brain cancer in partnership with OurBrainBank
Read the fascinating series on brain tumors, glioblastoma, technological potential, and stories of patient power.
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
